SCHEMBL20205632

SCHEMBL20205632

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc4c(c1)oc1c5ccccc5ccc41)c1oc4ccccc4c21)C(C)(C)c1cc(-c2ccc4c(c2)oc2c5ccccc5ccc42)c2oc4ccccc4c2c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 2/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ CYP1A1 P04798 7/20 0.34
▸ CYP1B1 Q16678 7/20 0.34
▸ CYP1A2 P05177 6/20 0.34
▸ ABCC1 P33527 5/20 0.34
▸ ABCG2 Q9UNQ0 5/20 0.34
▸ ABCB1 P08183 3/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PDE5A O76074 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205625 0.94 CYP1A1 (0.34) PRKDCALOX5PGRCYP1A1CYP1B1
SCHEMBL20205390 0.92 PRKDC (0.36) PRKDCALOX5PGRCYP1A1CYP1B1
SCHEMBL20205638 0.92 TDP1 (0.37) PRKDCALOX5PGRCYP1A1CYP1A2
SCHEMBL20205647 0.91 ALOX5 (0.38) PRKDCALOX5PGRL3MBTL1KDM4E
SCHEMBL20205623 0.89 PRKDC (0.34) PRKDCALOX5PGRKDM4EALDH1A1
SCHEMBL20205631 0.89 ALOX5 (0.36) PRKDCALOX5PGRCYP1A2L3MBTL1
SCHEMBL20205579 0.88 TDP1 (0.34) PRKDCCYP1A1CYP1A2ABCG2TDP1
SCHEMBL20205459 0.88 GPR84 (0.38) PRKDCALOX5PGRCYP1A1CYP1B1
SCHEMBL20205295 0.87 PRKDC (0.35) PRKDCALOX5PGRL3MBTL1KDM4E
SCHEMBL20205629 0.87 MMP12 (0.37) PRKDCALOX5PGRL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PRKDC 4001/4885ALOX5 354/4885PGR 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback